Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
0.440
-0.030 (-6.40%)
At close: Jan 6, 2025, 4:00 PM
0.445
+0.005 (1.16%)
After-hours: Jan 6, 2025, 7:50 PM EST
Relmada Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 6, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 13 | 125 | 105 | 625 | 521 | 554 | |
| Market Cap Growth | 8.27% | 18.62% | -83.18% | 19.93% | -6.06% | 796.18% | |
| Enterprise Value | -41 | 18 | -79 | 537 | 398 | 547 | |
| Last Close Price | 0.44 | 4.14 | 3.49 | 22.53 | 32.07 | 39.00 | |
| PB Ratio | 0.28 | 1.46 | 0.75 | 3.00 | 4.93 | 4.79 | |
| P/TBV Ratio | 2.05 | 1.46 | 0.75 | 3.00 | 4.93 | 4.79 | |
| Debt / Equity Ratio | - | - | - | - | - | 0.00 | |
| Quick Ratio | 6.69 | 7.90 | 11.94 | 14.08 | 9.30 | 79.92 | |
| Current Ratio | 6.89 | 8.00 | 12.26 | 14.83 | 9.37 | 80.21 | |
| Return on Equity (ROE) | -116.60% | -87.51% | -90.07% | -80.14% | -53.74% | - | |
| Return on Assets (ROA) | -69.48% | -51.76% | -53.57% | -46.01% | -31.52% | - | |
| Return on Capital (ROIC) | -77.22% | -57.41% | -57.80% | -50.07% | -33.51% | - | |
| Earnings Yield | -651.42% | -79.28% | -149.50% | -20.13% | -11.41% | -2.71% | |
| FCF Yield | -400.75% | -41.46% | -98.82% | -14.71% | -5.34% | -2.18% | |
| Buyback Yield / Dilution | -0.15% | -1.59% | -68.80% | -12.56% | -68.97% | -46.22% | |
| Total Shareholder Return | -0.15% | -1.59% | -68.80% | -12.56% | -68.97% | -46.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.